5-132658194-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_002188.3(IL13):c.8C>T(p.Pro3Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000187 in 1,601,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_002188.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL13 | NM_002188.3 | c.8C>T | p.Pro3Leu | missense_variant | 1/4 | ENST00000304506.7 | NP_002179.2 | |
IL13 | NM_001354991.2 | c.-92-96C>T | intron_variant | NP_001341920.1 | ||||
IL13 | NM_001354992.2 | c.-92-96C>T | intron_variant | NP_001341921.1 | ||||
IL13 | NM_001354993.2 | c.-22+950C>T | intron_variant | NP_001341922.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL13 | ENST00000304506.7 | c.8C>T | p.Pro3Leu | missense_variant | 1/4 | 1 | NM_002188.3 | ENSP00000304915 | P1 | |
TH2LCRR | ENST00000435042.1 | n.94+5985G>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000410 AC: 10AN: 244172Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131916
GnomAD4 exome AF: 0.0000179 AC: 26AN: 1449218Hom.: 0 Cov.: 28 AF XY: 0.0000153 AC XY: 11AN XY: 720352
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74364
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at